Cargando…
PReS-FINAL-2179: Efficacy and safety of adalimumab in pediatric patients with enthesitis related arthritis
Autores principales: | Burgos-Vargas, R, Tse, S, Horneff, G, Pangan, AL, Unnebrink, K, Anderson, JK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044167/ http://dx.doi.org/10.1186/1546-0096-11-S2-O14 |
Ejemplares similares
-
A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis‐Related Arthritis
por: Burgos‐Vargas, Rubén, et al.
Publicado: (2015) -
PReS-FINAL-2001: The impact of adalimumab on growth in patients with juvenile idiopathic arthritis
por: Ruperto, N, et al.
Publicado: (2013) -
PReS-FINAL-2137: Adalimumab monotherapy results in clinical and radiological improvement in newly diagnosed patients with juvenile spondylarthritis (JSPA)/enthesitis related arthritis(ERA)
por: Maritsi, D, et al.
Publicado: (2013) -
PReS-FINAL-2367: Academic training of pediatric rheumatologist in the Russian federation
por: Alekseeva, E, et al.
Publicado: (2013) -
PReS-FINAL-2366: Paediatric rheumatology in South Africa
por: Scott, C
Publicado: (2013)